Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
26-09-21	€0.1410	-0.70%	221,311
26-09-18	€0.1420	+1.43%	263,988
26-09-17	€0.1400	-2.23%	431,521
26-09-16	€0.1432	-2.32%	130,300
26-09-15	€0.1466	-8.37%	728,582

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 11:55:00 2026-09-21 EDT			5-day change	1st Jan Change
0.1410 ^EUR	-0.70%		-11.88%	-35.62%

09-10	Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East	CI
09-09	Klea Holding Launches Wellness Brand in Dubai	MT

Market Cap	43.29M 49.64M 40.77M 37.13M 69.61M 4.76B 69.7M 488M 188M 2.42B 186M 182M 7.82B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	43.41M 49.79M 40.89M 37.23M 69.81M 4.77B 69.9M 490M 189M 2.43B 187M 183M 7.84B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALKLH	Real-time
Deutsche Boerse AG	7V91	Delayed
Börse Stuttgart	7V91	Delayed
Boerse Muenchen	7V91	Real-time
Tradegate	7V91	Real-time

09-10	Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East	CI
09-09	Klea Holding Launches Wellness Brand in Dubai	MT
09-08	Klea Holding's Smart Health Unit to Open First Digital Medical Center in Saudi Arabia in Few Weeks	MT
09-07	Klea Holding Provides Update on the Opening of the 1St Digital Medical Centre in Riyadh	CI
08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI

Klea Holding Stock

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news: Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Price Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

09-10	Klea : Pharmaceuticals secures its first order and reaffirms its ambitions for strong and profitable growth	PU
09-10	Klea Holding : Klea Pharmaceuticals secures its first order and reaffirms its ambitions for strong and profitable growth	AT
09-08	Klea Holding : Klea Holding confirms the gradual resumption of operations at Smart Salem and launches the Klea Health brand to showcase its expertise in the wellness sector	AT
09-08	Klea : confirms the gradual resumption of operations at Smart Salem and launches the Klea Health brand to showcase its expertise in the wellness sector	PU
09-07	Klea Holding : Klea Holding provides an update on the imminent launch of its operations in Saudi Arabia	AT

09-14	Klea Holding : Déclaration des transactions sur actions propres
09-10	Klea Pharmaceuticals enregistre une première commande
09-10	Klea Holding : Klea Pharmaceuticals enregistre sa première commande et confirme ses ambitions de croissance forte et rentable
09-08	Klea Holding : Klea Holding confirme la reprise progressive d’activité de Smart Salem et lance la marque Klea Health pour valoriser son expertise dans le domaine du Wellness
09-08	Klea : confirme la reprise progressive d'activité de Smart Salem et lance la marque Klea Health pour valoriser son expertise dans le domaine du Wellness

1 day	-0.70%
1 week	-11.88%
Current month	-6.62%
1 month	-8.44%
3 months	-24.92%
6 months	-14.86%
Current year	-35.62%

1 week	0.14	0.15
1 month	0.14	0.17
Current year	0.14	0.25
1 year	0.14	0.31
3 years	0.14	0.39
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	2024-01-21
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	2022-03-31

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	2022-03-31
Paul Amsellem BRD	Director/Board Member	51	2023-06-13

Date	Insider	Type	Quantity	% Market Cap.
7/17/26	Raphael Smila	Buy	103,000	0.0335%
7/17/26	Raphael Smila	Buy	103,000	0.0335%
7/16/26	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.70%	-11.88%	-36.63%	-63.09%	49.99M
CVS HEALTH CORPORATION	-1.40%	-8.32%	+16.92%	+21.85%	114B
HCA HEALTHCARE, INC.	-0.41%	+0.11%	+5.88%	+68.08%	92.6B
FRESENIUS SE & CO. KGAA	-0.42%	+0.47%	-2.05%	+47.89%	29.66B
QUEST DIAGNOSTICS INCORPORATED	-0.64%	+2.94%	+33.38%	+98.25%	27.2B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-1.00%	-1.56%	-9.28%	-2.94%	21.43B
TENET HEALTHCARE CORPORATION	-0.39%	-1.34%	+37.25%	+287.60%	21.1B
REDE D'OR SÃO LUIZ S.A.	+2.39%	+3.19%	-8.61%	+44.28%	15.71B
FRESENIUS MEDICAL CARE AG	+0.41%	-1.79%	-10.19%	-8.82%	11.76B
DAVITA INC.	-0.83%	-3.69%	+40.09%	+78.14%	11.73B
Average	-0.06%	-1.90%	+6.68%	+57.12%	34.49B
Weighted average by Cap.	+0.15%	-2.59%	+11.93%	+59.12%

	2024	2025
Net sales	17.26M 19.8M 16.26M 14.8M 27.76M 1.9B 27.79M 195M 75.04M 966M 74.36M 72.71M 3.12B	22.17M 25.42M 20.88M 19.01M 35.65M 2.44B 35.69M 250M 96.36M 1.24B 95.5M 93.38M 4B
Net income	1.4M 1.61M 1.32M 1.21M 2.26M 154M 2.26M 15.85M 6.11M 78.64M 6.05M 5.92M 254M	2.28M 2.62M 2.15M 1.96M 3.67M 251M 3.67M 25.73M 9.92M 128M 9.83M 9.61M 412M
Net Debt	2.58M 2.95M 2.43M 2.21M 4.14M 283M 4.15M 29.04M 11.19M 144M 11.09M 10.85M 465M	125K 143K 118K 107K 201K 13.73M 201K 1.41M 543K 7M 539K 527K 22.58M